Search - tctmd.com

Displaying 621 - 640 of 1576

Sort: Relevancy | Date

Presentation TCT 2017

Why I Prefer Bivalirudin for Primary PCI in STEMI!

Presenter: Michael S. Lee, Dirk Sibbing, Uwe Zeymer

October 30, 2017

Presentation TCT 2017

Strengths and Limitations of Composite Endpoints (eg, EXCEL, PLATO, and Others)

Presenter: Roxana Mehran, Robert W. Yeh, Stuart J. Pocock

October 30, 2017

Presentation TCT 2017

Is There a Role for Dedicated Stents or Bioresorbable Scaffolds in the Treatment of Complex Bifurcation Disease?

Presenter: Walter Desmet, Guy J. Friedrich, Eduard Margetic, Christophe Dubois

October 30, 2017

Presentation TCT 2017

STEMI With Cardiogenic Shock and Cardiac Arrest: What Do the US Guidelines and AUC Say?

Presenter: Sripal Bangalore, Manesh R. Patel, Gregory J. Dehmer

October 30, 2017

Presentation TCT 2017

New Insights Into Neoatherosclerosis and Other Causes of Metallic Stent Thrombosis: Will the Most Dreaded Complication Always Be With Us?

Presenter: Dean J. Kereiakes, Spencer B. King III, Aloke V. Finn

October 30, 2017

Presentation TCT 2017

Anatomy and Pathology of Left Main and Non Left Main Bifurcations: Similarities and Differences

Presenter: Davide Capodanno, David Hildick-Smith, Tom Johnson

October 30, 2017

Presentation TCT 2017

A CHIP Case Presentation

Presenter: Thomas H. Maloney, Justine Alexander, Sheila Sahni

October 30, 2017

Presentation TCT 2017

Why I Prefer a Heparin Plus a GPI for Primary PCI in STEMI!

Presenter: Michael S. Lee, Dirk Sibbing, Eric R. Bates

October 30, 2017

Presentation TCT 2017

PROPHET II Trial Summary and Clinical Implications

Presenter: Prashant Kaul, Jennifer A. Tremmel, Samir B. Pancholy

October 30, 2017

Presentation TCT 2017

Is There a Need for Dedicated Bifurcation Stents (Bare Metal or Drug-Eluting)?

Presenter: Alaide Chieffo, Jeffrey W. Moses, Martin B. Leon

October 30, 2017

Presentation TCT 2017

Very Late Stent Failures and Non-Stent Related Events: Insights Into Improving Event-Free Survival

Presenter: Dean J. Kereiakes, Spencer B. King III, Lorenz Raber

October 30, 2017

Presentation TCT 2017

How to Interpret Trials That Are Stopped Early (eg, PRAMI, FAME II, DECISION CTO, and Others)

Presenter: Roxana Mehran, Robert W. Yeh, Laura Mauri

October 30, 2017

Presentation TCT 2017

Bifurcation Literature Review: New Data From 2016-17

Presenter: Davide Capodanno, David Hildick-Smith, Tom Johnson

October 30, 2017

$Why I Prefer Unfractionated Heparin Without GPI for Primary PCI in STEMI!$

Presentation TCT 2017

Why I Prefer Unfractionated Heparin Without GPI for Primary PCI in STEMI!

Presenter: Michael S. Lee, Dirk Sibbing, A. Michael Lincoff

October 30, 2017

Presentation TCT 2017

STEMI With Cardiogenic Shock and Cardiac Arrest: What Do the Data and EU Guidelines Say?

Presenter: Sripal Bangalore, Manesh R. Patel, Holger Thiele

October 30, 2017

Presentation TCT 2017

The History of Bifurcation Treatments: Key Milestones Along the Way

Presenter: Davide Capodanno, David Hildick-Smith

October 30, 2017

Presentation TCT 2017

STEMI Case Presentation: Why the Choice of Patental Therapy Matters

Presenter: Michael S. Lee, Dirk Sibbing, Francesco Franchi

October 30, 2017

Presentation TCT 2017

PCI With DES and DEB for Treatment of "True" Coronary Artery Bifurcation Lesions

Presenter: Walter Desmet, Guy J. Friedrich, Eduard Margetic, Jozica Sikic

October 30, 2017

Presentation TCT 2017

Keynote Lecture: Hemodynamic Support in CHIP - Which Device, in Whom, and When?

Presenter: Thomas H. Maloney, Emmanouil S. Brilakis

October 30, 2017

Presentation TCT 2017

Keynote Lecture: A Brief 40-Year History of PCI - How Far We've Come, How Far We Have to Go

Presenter: Dean J. Kereiakes, Spencer B. King III, Robert A. Byrne

October 30, 2017

Advertisement

Why I Prefer Bivalirudin for Primary PCI in STEMI!

Strengths and Limitations of Composite Endpoints (eg, EXCEL, PLATO, and Others)

Is There a Role for Dedicated Stents or Bioresorbable Scaffolds in the Treatment of Complex Bifurcation Disease?

STEMI With Cardiogenic Shock and Cardiac Arrest: What Do the US Guidelines and AUC Say?

New Insights Into Neoatherosclerosis and Other Causes of Metallic Stent Thrombosis: Will the Most Dreaded Complication Always Be With Us?

Anatomy and Pathology of Left Main and Non Left Main Bifurcations: Similarities and Differences

A CHIP Case Presentation

Why I Prefer a Heparin Plus a GPI for Primary PCI in STEMI!

PROPHET II Trial Summary and Clinical Implications

Is There a Need for Dedicated Bifurcation Stents (Bare Metal or Drug-Eluting)?

Very Late Stent Failures and Non-Stent Related Events: Insights Into Improving Event-Free Survival

How to Interpret Trials That Are Stopped Early (eg, PRAMI, FAME II, DECISION CTO, and Others)

Bifurcation Literature Review: New Data From 2016-17

Why I Prefer Unfractionated Heparin Without GPI for Primary PCI in STEMI!

STEMI With Cardiogenic Shock and Cardiac Arrest: What Do the Data and EU Guidelines Say?

The History of Bifurcation Treatments: Key Milestones Along the Way

STEMI Case Presentation: Why the Choice of Patental Therapy Matters

PCI With DES and DEB for Treatment of "True" Coronary Artery Bifurcation Lesions

Keynote Lecture: Hemodynamic Support in CHIP - Which Device, in Whom, and When?

Keynote Lecture: A Brief 40-Year History of PCI - How Far We've Come, How Far We Have to Go

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content